#None #Alzheimer's Disease #Mild Cognitive Impairment #Sleep EEG

Understanding Sleep and its Relation to Alzheimer’s Disease

Sleep plays a vital role in processes such as memory consolidation and neural repair, positioning it as a key biological signal in the context of aging and neurodegenerative diseases. A noteworthy focus of ongoing research is how sleep disturbances might serve as one of the earliest indicators of Alzheimer’s Disease (AD) and mild cognitive impairment (MCI).

In an upcoming webinar hosted by Xtalks, experts will delve into how sleep electroencephalograms (EEGs) can detect early biological changes linked to Alzheimer's. The highlighted elements of discussion include slow-wave sleep, sleep spindles, and microarchitecture of sleep—all of which offer potential tools for defining patient populations and monitoring disease progression.

The Connection Between Sleep and Neurodegeneration

Disrupted sleep patterns have been identified as critical symptoms preceding the clear cognitive decline associated with Alzheimer’s, often appearing years in advance of memory loss. Researchers noted that these sleep disturbances could arise even before any pathological changes are observed in the brain. By investigating how sleep EEG can assist in the early detection of Alzheimer’s pathophysiology, the webinar aims to shed light on innovative trial designs for AD and MCI.

During the session, featured speakers will discuss the direct relationship between disrupted sleep and neurodegenerative pathways. Topics covered will include synaptic homeostasis, neuroinflammation, and the brain’s ability to clear metabolic waste. For instance, slow-wave sleep has been linked to the glymphatic clearance system, responsible for removing amyloid-beta and tau proteins from the brain—two key players in Alzheimer’s pathology. A single night of poor sleep can noticeably elevate cerebrospinal fluid (CSF) amyloid-beta levels, and studies have shown that lower slow-wave activity correlates with an increased amyloid burden detectable through positron emission tomography (PET) scans.

Early Detection and Clinical Implications

Attendees of the webinar will learn how these sleep metrics not only provide an early functional readout—prior to standard cognitive testing—but can also effectively track clinical improvements. The spindles in conjunction with slow-wave activity are believed to predict memory decline in cognitively healthy individuals as they age. Since sleep metrics can change significantly in a matter of days to months, they present a unique opportunity for researchers to monitor amyloid accumulation and anticipate cognitive decline over a 6-24 month window, which is ideal for interim analyses during clinical trials.

The discussion will also cover strategies for identifying biomarker-positive patients who do not yet show cognitive impairment and how sleep EEG could facilitate their earlier enrollment into studies than current diagnostic approaches typically allow. By integrating sleep EEG endpoints into trial design, researchers can better capture treatment effects, support timely interim analyses, and characterize patient responses more effectively.

Join the Discussion

This pivotal webinar features prominent experts in the field, including Dr. Jacobo E. Mintzer, a distinguished fellow of the American Psychiatric Association and a professor at the Medical University of South Carolina, and Dr. Joseph R. Winer, a neuroscientist at the California Pacific Medical Center Research Institute. Ky Pathmanathan, Senior Medical Director at Beacon Biosignals, will also contribute insights on the utility of sleep metrics in clinical settings.

Scheduled for September 2, 2026, at 1 PM EDT, this event is indispensable for those seeking to deepen their understanding of the critical relationship between sleep and Alzheimer’s detection. To register and join these experts in the exploration of this significant topic, visit the Xtalks website for more information.

About Xtalks

Xtalks serves the life sciences community by empowering professionals across various sectors including pharma, biotech, and healthcare with trusted knowledge and collaborative insights. Its resources—ranging from articles to webinars—provide valuable support for those navigating the fast-paced world of medical research and development.